The early region 1A (E1A) gene of adenovirus 5 encodes two proteins, 289AA and 243AA, which are translated from mRNAs of 13S and 12S, respectively. These two ElA proteins are identical except for an internal stretch of 46 amino acids unique to the larger protein. The 289AA protein activates transcription from promoters of other early adenoviral genes. The adenovirus type 5 host range mutants hr3, hr4, and hr5 are unable to activate transcription of these early viral genes. We show here that hr3, hr4, and hr5 each contain a distinct missense mutation in the ElA gene. We first localized the mutations in a series of constructed wild-type-hr hybrid ElA genes by using a biological assay which can discriminate between functional and nonfunctional ElA proteins. We then identified the mutations by DNA sequencing. In hr3 lysine replaced methionine at position 176, and in hr4 phenylalanine replaced leucine at position 173; both substitutions occurred in the region unique to the 289AA protein. In hr5, due to the splicing patterns of the two mRNAs, asparagine replaced serine as the last amino acid in the unique region of the 289AA protein at position 185, while aspartic acid replaced glycine at position 139 in the 243AA protein, which is the last amino acid common to both proteins before the unique region. These results substantiate the role of the 289AA protein in transcriptional activation and underscore the importance of the unique region as the basis of the functional difference between the two ElA proteins. Implications as to how these mutations affect the structure and function of the ElA proteins in transcriptional activation and transformation are discussed.
The early region 1A (ElA) gene of adenovirus is dynamic in its ability to regulate expression of both viral and cellular genes. The adenovirus genome consists of linear doublestranded DNA that is 35 kilobase pairs in length. The ElA gene is located between 1.5 and 4.5 map units (m.u.) on the adenovirus genome. Upon infection, expression of the ElA gene facilitates transcription from early viral promoters E1B, E2, E3, and E4 (2, 11, 26, 35, 41) . In addition, ElA gene products are able to activate transcription of the mammalian heat shock gene (37) as well as certain cellular genes introduced into cells as recombinant DNA molecules by transfection or infection (12, 18, 47, 49) . The ElA gene also plays a critical role in the ability of adenovirus to morphologically transform cells in vitro. Although transformation by adenovirus requires the expression of both ElA and E1B genes (8, 10, 17) , recent studies have shown further that the ElA gene per se can immortalize primary cells (25) as well as cooperate with the polyoma middle-T and T24 H-ras-1 oncogenes to transform cells in culture (29, 43) .
The ElA gene encodes overlapping RNAs of 9S, 12S, and 13S which share the same 5' and 3' termini but which differ in length due to the amount of intervening sequences removed by splicing (3, 6, 28, 38, 45) . Each of the ElA RNAs shares the same acceptor splice site but uses a different donor splice site (3, 38, 45) . The 12S and 13S RNAs of ElA are the first viral genes to be transcribed upon infection; the 9S RNA is made at late times of infection (2, 26, 45) . In adenovirus 5 (AdS), the 12S and 13S RNAs encode protein products of 243 and 289 amino acids (designated proteins 243AA and 289AA), respectively. These ElA proteins are identical except for an internal stretch of 46 amino acids unique to the large protein (38 (35, 41) . In hrl, the 289AA protein is truncated due to a frameshift mutation in the unique coding region, whereas the 243AA protein is of normal length (41) . ElA is the only viral gene transcribed upon infection by hrl (2, 41) . In pm975, a point mutation disrupts the donor splice site of the 12S RNA and thereby permits only the 289AA protein product of the 13S RNA to be synthesized (35) . The pm975 mutant, unlike hrl, undergoes a normal productive infection in HeLa cells (35) .
Analysis of missense mutants may help to delineate domains of the ElA proteins essential for function. Although ElA missense mutants have not been described, three mutants, hr3, hr4, and hr5, were predicted to contain missense mutations in ElA (41) . The mutations were generated by treatment of AdS virions with UV irradiation in the case of hr3 or with nitrous acid in the cases of hr4 and hr5 (21) . The mutant viruses were isolated on 293 cells (15) , which constitutively express both ElA and E1B genes (1) . For each of these mutants, the defect was mapped to the ElA gene by marker rescue (9) . These mutants were defective for both growth on HeLa cells (21) and their ability to transform primary rat embryo cells (14) . As in the case of hrl, these mutants expressed only ElA transcripts upon infection (30) .
hr3, hr4, and hr5 were suggested to be missense because they each synthesized both the 289AA and the 243AA proteins indistinguishable from wild-type (WT) virus as judged by two-dimensional gel electrophoresis (41, 42) . This was true whether the ElA proteins were translated in vitro from hybridization-selected RNA (41) or synthesized in vivo and immunoprecipitated with ElA-specific antisera (42) .
AdS ElA MISSENSE MUTANTS 67 In this study we have determined the specific mutations in hr3, hr4, and hr5. For each mutant, we first identified a segment of the coding region of the ElA gene which was defective and then characterized the specific mutation by DNA sequencing. Our analysis demonstrates that hr3, hr4, and hr5 are indeed missense mutants. The predicted amino acid substitutions and their effects on the structure of the ElA proteins are presented.
MATERIALS AND METHODS
Cells and viruses. 293 cells (15) were propagated in Dulbecco modified Eagle medium (DMEM) with 10% fetal calf serum. Monolayer cultures of HeLa cells were grown in MEM containing 8% fetal calf serum. Seed stocks of the host range mutant viruses, Ad5 hr3, Ad5 hr4, and Ad5 hr5, were obtained from Jim Williams (Carnegie Mellon University, Pittsburgh, Pa.). 293 cells were infected with the mutant viruses at a multiplicity of 1 PFU. After 60 h, virions were purified by CsCl gradient centrifugation (39) . Viral DNA was purified as described previously (39) .
Plasmids. Plasmid pLA1, containing the left end 9.4% of the AdS genome, was obtained from F. Tamanoi (Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.) (48) . Plasmids p3CAT(pKCAT23) and p2CAT, which consist of the bacterial chloramphenicol acetyltransferase (CAT) gene driven by the E3 or E2 promoter of adenovirus, respectively, were generous gifts from N. C. Jones (Purdue University, West Lafayette, Ind.) (52) . Plasmid constructions are described in the text. Restriction endonucleases were obtained from Bethesda Research Laboratories (BRL) and New England Biolabs, T4 DNA ligase was from Boehringer Mannheim Biochemicals, and Klenow fragment and EcoRI linkers were from BRL. DNA fragments were purified from agarose gels by the method of Vogelstein and Gillespie (51) . Ligation and nick translation of DNA with [a&2P-labeled nucleoside triphosphates (Amersham Corp.) were as described previously (32) . After transformation of Escherichia coli (C600) to ampicillin resistance, plasmids were screened by colony hybridization (19) or restriction enzyme analysis of plasmid DNA isolated from minilysates (23) . Plasmids were purified by using standard procedures (27, 40) .
Transfections and CAT assays. Plates of HeLa cells were transfected by the calcium phosphate precipitation technique (16) followed by a glycerol shock (9) . Plasmid DNA (10 jig of p3CAT alone or together with 2.5 jig of an E1A-containing plasmid) was first suspended in 438 j,l of 10 mM Tris-1 mM EDTA (pH 7.9) and then 62 jil of 2 M CaC12 was added. The CaCl2-DNA mixture was added to an equal volume of 2 x HEPES-buffered saline (280 mM NaCl, 50 mM HEPES [N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid], 1.5 mM Na2HPO4, pH 7.1) while air bubbles were simultaneously introduced into the solution. Precipitates were allowed to form at room temperature for 30 to 45 min.
The precipitate was added to a 100-mm plate of cells containing 9 ml of MEM and cultures were incubated at 37°C for 4 to 6 h. The medium was removed, and the cells were shocked for 1 min with MEM containing 20% glycerol, washed with medium, and refed with 20 ml of MEM containing 8% fetal calf serum.
After 48 h, cells were harvested and the cell extracts were assayed for CAT activity as described by Weeks and Jones (52) . For standardization, CAT assays were performed with extracts containing equal amounts of protein (31) . In all instances, the CAT assays were highly reproducible.
M13 cloning and sequencing. M13 vectors mpl8 and mpl9 and E. coli strain JM107 were used for cloning and sequencing. The relevant fragment from each host range mutant was cloned into M13, and after positive recombinants were identified, single-stranded phage DNA was prepared (33) . DNA was sequenced with chain-terminating dideoxynucleotides by the method of Sanger et al. (44) with [35S]dATP (650 Ci/mmol; Amersham) as the labeled nucleotide (4). Deoxy-dideoxynucleotide mixes were obtained from P-L Biochemicals. Primer and Klenow fragment were from BRL. Sequences were fractionated on 6 and 8% polyacrylamide gels (40% polyacrylamide-2% bisacrylamide, ultrapure reagents; BRL) containing 8 M ultrapure urea (BRL). Gels were dried and exposed for 24 to 48 h, using Kodak XAR-5 X-ray film.
Computer analysis. The predicted secondary structures were generated by computer analysis, using the programs of Chou and Fasman (5) and Hopp and Woods (24) . RESULTS Cloning of WT and hr3, hr4, and hr5 ElA genes. The left end of adenovirus encodes two overlapping ElA transcripts of 13S and 12S, as depicted by a generalized restriction map of this region in Fig. 1A . The WT ElA gene was subcloned from plasmid pLA1, which contains the 0-to 9.4-m.u. portion of the Ad5 genome. pLA1 was digested with EcoRI and KpnI to generate the 0-to 6.1-m.u. fragment (Fig. 1B) . The KpnI end of the 0-to 6.1-m.u. fragment was modified by EcoRI linker attachment and cloned into plasmid pML to obtain pElA (Fig. 1B) .
The ElA genes of host range mutants hr3, hr4, and hr5 were obtained directly from their respective viral DNAs. The left end XhoI C fragment (0 to 15.5 m.u.) was isolated and further restricted to obtain the SacII-SacI fragment that extends from 354 to 1,770 base pairs (bp) (Fig. 1C) . The corresponding SacII-SacI fragment of the WT ElA gene was removed from pElA and replaced with the SacII-SacI fragment of each host range mutant (Fig. 1C ). In the three resulting plasmids, pHR3, pHR4, and pHR5, the promoter, coding region, and poly(A) addition sites of ElA are derived from host range sequences, whereas flanking sequences, including upstream enhancers, are derived from the WT gene ( Fig. 1A and C) .
Biological assay that discriminates between WT and host range ElA genes. Since random mutagenesis was used to produce the host range mutants, silent mutations could be present in addition to the mutation which accounts for the defective phenotype. It was thus important to have a convenient assay which could discriminate between a functional and nonfunctional ElA gene to (Fig. 3) . The three restriction fragments chosen for this exchange and the portion of the In Fig. 3 , all of the plasmids contain ElA-coding regions derived from the WT DNA sequence, denoted by a W, or from host range DNA sequences, denoted by an H. For example, plasmid pWHW encodes hybrid 289AA and 243AA ElA proteins of which the amino-terminal and carboxyl-terminal portions are WT and the middle portions are host range. Thus, for each host range mutant, hr3, hr4, and hr5, this series of six hybrid ElA genes was available for testing in the CAT assay system.
(ii) CAT assay with hybrid ElA genes. Each of the hybrid ElA genes was tested in the CAT assay system as described above. For all of the host range mutants, high levels of CAT activity were induced when p3CAT was cotransfected with pHWW, pHWH, and pWWH (Fig. 4, lanes 6, 7, and 10 , respectively). On the other hand, for each host range mutant, low levels of CAT activity were induced with pWHH, pWHW, and pHHW (lanes 5, 8, and 9, respectively). The intensity of the spots induced by the former set of hybrids E OS J. VIROL. corresponded to those induced by WT pElA (Fig. 4 , cf. lane 3 with lanes 6, 7, and 10), whereas the intensity of the spots induced by the latter set of hybrids corresponded to those induced by host range pHR3, pHR4, and pHR5 (Fig. 4 , cf. lane 4 with lanes 5, 8, and 9). These analyses revealed that for each host range mutant, whenever the middle segment (SmaI-XbaI) of a hybrid ElA gene was derived from host range sequences, as in pWHH, pWHW, and pHHW, low levels of CAT activity were observed after cotransfection with p3CAT (Fig. 4, lanes 5, 8,  and 9 ). Conversely, whenever WT sequences were present in the middle segment of the hybrid ElA, as in pHWW, pHWH, and pWWH, the resulting hybrid gene was able to induce a high level of CAT activity (Fig. 4, (44) . The nucleotide sequence containing the mutation in each host range mutant is shown in Fig. 5 . hr3, hr4, and hr5 each contained a single nucleotide change as compared to the published sequence of Ad5 ElA (50) . In addition, these three host range sequences served as controls for one another since two of them had the nucleotide of the WT ElA at the position of the mutation in the third host range sequence. There is a transversion from T to A at nucleotide 1086 in hr3, a transition from C to T at position 1076 in hr4, and a transition from G to A at nucleotide 1229 in hr5 (Fig. 6) .
The mutation in each host range mutant produces singleamino acid substitutions and thus confirms the earlier hypothesis that these are indeed missense mutants (41) . The actual amino acid substitutions are depicted in Fig. 6 (41) . These are the first missense mutants to be reported in ElA. These mutants are defective for both normal infection and transformation (14, 21) . Since they were derived by random mutagenesis, there was the possibility that the defective ElA gene could also contain silent mutations. Therefore, prior to DNA sequencing, we localized the mutation to a specific segment of the coding region of ElA. This was done by testing hybrid EIA genes containing both WT and host range sequences in a biological assay that detects the ability of ElA to activate transcription from inducible adenoviral promoters (52) .
In hr3 and hr4, single-base-pair changes occur within the region unique to the 13S RNA and generate amino acid substitutions which affect only the 289AA protein. In hr5, a single-base-pair alteration produces missense mutations which affect both the 289AA and the 243AA proteins. In the 289AA protein, the last amino acid of the unique region is changed and in the 243AA protein the last amino acid common to both proteins before the unique region is changed. These results substantiate the role of the 289AA protein in transcriptional activation (35, 41) and underscore the importance of the unique region as the basis of the functional differences between the two ElA proteins.
The novel feature of the defect in hr5 is that this single mutation is able to simultaneously produce a missense mutation in both the 289AA and the 243AA proteins in nonidentical regions. The split codons [i.e., 5 It is noteworthy that, although the nucleotide substitution of G to A at position 1229 in hr5 is adjacent to the 3' boundary of the intron, both the 12S and the 13S RNAs are properly spliced as determined by S1 analysis (30; unpublished data). This is not unexpected since both G and A are frequently used as the first nucleotide of the downstream exon (36) . (Fig. 7B ). In hr5, there was no apparent change in the hydrophilicity in the region of the mutation of the 289AA protein (Fig. 7B) from the cysteine at position 174. In hr4, an amino acid with an aromatic group (phenylalanine) replaces one which is less space filling (leucine) at a position adjacent to cysteine 174. It is possible that these mutations may interfere with potential intra-or intermolecular disulfide bridges formed by these cysteines and thereby disrupt the tertiary conformation of the 289AA protein.
The host range mutant viruses, hrl, hr2, hr3, hr4, and hr5, are equally defective in their abilities to infect HeLa cells (21) , but exhibit differences in their abilities to transform primary rat embryo cells (22) . hrl and hr2 are cold sensitive for transformation; i.e., they form foci at 38.5°C but not at 32.5°C, whereas hr3, hr4, and hr5 are unable to form foci at either temperature (22) . An important difference between these two classes of mutants is that hrl and, predictably, hr2 encode a 243AA protein of normal length but truncated forms of the 289AA protein (41) . In contrast, hr3, hr4, and hr5 are each missense mutants as shown here and encode both proteins of normal length (41, 42) . The cold-sensitive phenotype observed with hrl could be due to the action of the 243AA protein since viral mutants which express the 243AA protein, but not the 289AA protein, are also cold sensitive for transformation (20, 34) . In light of these observations, there are two possible explanations which could account for the reason that hr3, hr4, and hr5 fail to transform primary rat embryo cells at the high temperature. First, there may be an overlooked mutation in another region of the ElA gene of hr3, hr4, or hr5 which makes them defective for transformation since this study only measured the ability of ElA to activate transcription from viral promoters. However, in the case of hr5, the single mutation could account for the transformation-defective phenotype since it affects both the 289AA and the 243AA ElA proteins, If second mutations specifically affecting transformation do exist, they are predicted to reside in the 5' end of the coding region in the case of hr4 and hr5 (nucleotides 560 to 1007) since the 3' ends of these mutants (nucleotides 1339 to 1572) were sequenced and found to be completely wild type (data not shown). In hr3 such a mutation could reside in either the 5' or the 3' end of the gene. A second explanation may account for the inability of hr3, hr4, and hr5 to transform at the higher temperature. In each of these mutants, the full-length 289AA protein which contains a single-amino-acid substitution may interfere with the transforming activity of the 243AA protein.
